With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
BD and Waters set Feb. 9 completion date for $17.5B biosciences and diagnostics merger
BD and Waters have set Feb. 9 as the completion date for their $17.5 billion biosciences and diagnostics merger, following Waters’ stockholders’ approval of issuing shares to fund the deal. The plan spins off BD’s biosciences and diagnostics unit and merges it with a Waters subsidiary, giving BD shareholders about 39.2% of the combined company…